Farmacy

Jan 15 2018

Patient Summit Europe, eye for pharma.#Eye #for #pharma

15 th Annual Patient Summit Europe 17 – 18 October, 2018 | London, UK Buy the Post Conference Materials The Medicine is Just the Beginning Use patient insight to deliver holistic health impact – and a streamlined business plan We know we need to be patient centric. But we’ll never get there unless every department realigns itself and creates the ‘virtuous circle’ that will revive our market access goals, sales performance and our ability to resonate with customers. We need to fast-track our wholesale cultural change and instil practical frameworks which enable patient interaction to increase across our companies. This …

Jan 14 2018

Compiere Open Source ERP – A Modern, Low-cost ERP Software Solution, crm for pharma.#Crm #for

Compiere ERP Software Compiere is the leading Cloud-based, ERP software and customer relationship management (CRM) system provided by Aptean (www.aptean.com). Unlike on premise ERP solutions, Compiere allows you to easily extend its core functionality to fit your specific processes without forcing you into an expensive and difficult upgrade path. Compiere solutions provide businesses, government agencies, and non-profit organizations with easy, flexible, low-cost access to rich functionality for managing all financial, distribution, sales, and service processes. With Compiere, customers can easily and affordably customize the solution to fit their business requirements with no or minimal programming. The companies we serve. Compiere’s …

Jan 8 2018

India – s first CRM for Pharma used by 10k Medical Reps in 5 countries

#crm for pharma # Mobile Daily Call Reporting(DCR) Medismo On Demand Healthcare Mobile CRM lets you report from anywhere. MRs can Track Doctor Previous Call History, Stop False Reporting via GPS Tracking. Use the power of Medismo Pharma Mobile CRM to track your Medical rep locations and travel expenses sitting in Head Office. Pharma CRM in SaaS The BI Reporting engine can give reports in Realtime to track sales sales funnel so that the Managers can take proactive action. CEOs and Managers have access to a Single screen snapshot of sales, performance, competitor activity, expenses to the company much more. …

Jan 8 2018

Pharma Software for Distribution & Wholesale Billing #hra #pharma

#pharma software # Pharma Software Software Demo Multi Rate, Price List, & Discount Cash / Credit / Split Invoice & Challan Sales Return & Replacement on Sale Bill Party Wise Rate, Discount and Scheme Salesman / Route / Area Wise Bills & Reports Indication for Loss, Min, Max, New / Old Rate & Expiry Negative Stock Billing Facility Self-Designed Price List (Set Formula in Price List) Sales Return on Same / Separate Bill & Its Adjustment Back Date Stock Position at the Time of Billing Switch Over from Bill to Bill Anywhere Godown Wise Billing & Stock Position Bill Import …

Jan 7 2018

UCB to buy Schwarz Pharma for $5 #biotech #company

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …

Jan 7 2018

Actavis to Buy Forest Laboratories for $25 Billion #penn #pharma

#forest pharma # Actavis to Buy Forest Laboratories for $25 Billion Actavis Plc, the world’s second-largest generic-drug maker by market value, agreed to buy Forest Laboratories Inc. for about $25 billion in a deal that will transform it into a developer of brand-name drugs. The deal is a win for billionaire investor Carl Icahn, Forest’s second-largest holder who gained seats on the company’s board in 2012 and 2013, and pushed for a sale. Forest investors will get cash and stock valued at $89.48 a share, based on the Feb. 14 closing price, the companies said today in a statement. The …

Jan 7 2018

Is Pharmaceutical Sales Right for You? #medical #market #research

#pharmaceutical sales industry # Is Pharmaceutical Sales Right for You? By Holly Larsen | Monster Contributing Writer Why do so many people want to work in pharmaceutical sales? The biopharmaceutical industry seems to radiate success in a world where so many other enterprises are floundering. Another strong attraction is the job itself, which offers freedom, variety and challenges. Finally, the job s earnings potential and perks also draw interest. Strong, Stable Industry The modern pharmaceutical industry should thrive as long as people need medical treatment. In the US, pharmaceutical companies employ more than a quarter of a million people and …

Jan 7 2018

Teva to buy Barr Pharma for more than $7b #hra #pharma

#barr pharma #from the September 2008 issue Teva to buy Barr Pharma for more than $7b. Teva Pharmaceutical confirmed its purchase of rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva’s dominance as the world’s largest generic drugmaker. The deal continues consolidation of the generic-drug sector, driven by growth prospects as governments and other payers turn to the lower-priced medications and by the impending expiration of brand-name drug patents worth billions of dollars a year. Israel-based Teva Pharmaceutical Industries Ltd. said acquiring Montvale, N.J.-based Barr Pharmaceuticals Inc. the world’s No. 4 generic drug …

Jan 7 2018

Sun Pharma to buy Dusa for $230 million #schwarz #pharma

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

Jan 7 2018

Amgen to Buy Onyx for $10 #pharma #headhunters

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …